Literature DB >> 14756436

Tumor markers and colorectal cancer: utility in management.

Nigel P S Crawford1, Daniel W Colliver, Susan Galandiuk.   

Abstract

Colorectal cancer (CRC) is a leading cause of morbidity and mortality. Although genetic testing can screen for rare hereditary CRC syndromes, there is no ideal means of screening for sporadic forms of CRC. This review will focus on markers that are currently used in the management of sporadic CRC and their limitations, as well as possible future clinical applications.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14756436     DOI： 10.1002/jso.10325

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  12 in total

1.  Identification of proteins of human colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry.

Authors:  Ying-Tao Zhang; Yi-Ping Geng; Le Zhou; Bao-Chang Lai; Lv-Sheng Si; Yi-Li Wang
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

2.  A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.

Authors:  Damien Besson; Aude-Hélène Pavageau; Isabelle Valo; Anthony Bourreau; Audrey Bélanger; Caroline Eymerit-Morin; Alice Moulière; Agnès Chassevent; Michelle Boisdron-Celle; Alain Morel; Jerôme Solassol; Mario Campone; Erick Gamelin; Benjamin Barré; Olivier Coqueret; Catherine Guette
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

3.  Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.

Authors:  Ingrid Babel; Rodrigo Barderas; Ramón Díaz-Uriarte; Jorge Luis Martínez-Torrecuadrada; Marta Sánchez-Carbayo; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2009-07-28       Impact factor: 5.911

4.  Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Authors:  Jung-hyun Rho; Shuzhen Qin; Julia Y Wang; Michael H A Roehrl
Journal:  J Proteome Res       Date:  2008-06-13       Impact factor: 4.466

5.  Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.

Authors:  Ayman Eldesoky; Ashraf Shouma; Yousef Mosaad; Amira Elhawary
Journal:  Saudi J Gastroenterol       Date:  2011 May-Jun       Impact factor: 2.485

6.  Association of CTTN polymorphisms with the risk of colorectal cancer.

Authors:  Seok Youn Lee; Dong Baek Kang; Won Cheol Park; Jeong Kyun Lee; Soo Cheon Chae
Journal:  J Korean Surg Soc       Date:  2012-02-27

7.  Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer.

Authors:  Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Yoon Young Cho; Byung Min Ahn; Joon Ho Moon; Seoung Woo Jeon; Jae Yong Park; In Taek Lee; Gyu Seog Choi; Soo-Han Jun
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

Review 8.  Ectokinases as novel cancer markers and drug targets in cancer therapy.

Authors:  Garif Yalak; Viola Vogel
Journal:  Cancer Med       Date:  2014-12-14       Impact factor: 4.452

9.  Proteomic analysis of colorectal cancer: prefractionation strategies using two-dimensional free-flow electrophoresis.

Authors:  Robert L Moritz; Anita R Skandarajah; Hong Ji; Richard J Simpson
Journal:  Comp Funct Genomics       Date:  2005

10.  New insights into the role of age and carcinoembryonic antigen in the prognosis of colorectal cancer.

Authors:  P G Gobbi; F Valentino; E Berardi; C Tronconi; S Brugnatelli; O Luinetti; R Moratti; G R Corazza
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.